ECE2020 Audio ePoster Presentations Bone and Calcium (121 abstracts)
1Shamir medical center, Internal medicine A, Tzrifin, Israel; 2Shamir medical center, Internal Medicine C, Endocrine institute, Tzrifin, Israel; 3Shamir medical center, Endocrine Institute, Tzrifin, Israel; 4Lin Endocrine Research Center, Haifa, Israel; 5Shamir medical center, Polio Clinic Department of Orthopedics, Tzrifin, Israel; 6Shamir medical center, Internal Medicine A, Endocrine institue, Tzrifin, Israel
Objective: While osteoporotic fractures are reported in up to 40% of post-poliomyelitis adults, clinical guidelines regarding bone mineral density (BMD) testing and best timing for initiating treatment in this population are scarce. We assessed the characteristics of post-poliomyelitis patients, focusing on fracture and osteoporosis as the primary outcomes.
Methods: We conducted a cross-sectional retrospective data analysis from medical records of 204 post-poliomyelitis patients regarding their clinical characteristics, acute poliomyelitis disease and bone metabolism status.
Results: Our cohort included 53% females, mean age was 65 years (yrs.) at study entry and 1.7 yrs. at diagnosis of acute poliomyelitis. The lower limb was involved in 97.5% of patients, and the BMD in the affected limb was lower than the unaffected one (T score (Tsc) −1.64 vs −1.19, respectively; P = 0.06). This difference was more evident in males than females (Tsc-1.85 vs −1.02, respectively; P = 0.07), and in the fracture vs the non-fracture group (T-1.9 vs −1.25, respectively; P = 0.09). Recurrent falls were documented in 39.2% of patients. Osteoporosis was diagnosed in 20.6% of patients and was more frequent in females (P = 0.003) and patients with fractures (P = 0.002). At least one fracture occurred in 52.2% of patients, and more than one in 40.3%, with a mean age of 57 yrs. at the first fracture. Most patients fractured their affected limb (73.1%).
Conclusion: Despite the high fracture risk, osteoporosis in late-adulthood post-poliomyelitis patients appears to be underdiagnosed and undertreated. A comprehensive bone health assessment and early initiation of treatment, including anabolic agents, should be considered in this population.